Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data

TFAP2B expression may be a potential prognostic molecular marker of poor survival in endometrial cancer, Moreover, the p53/hypoxia, androgen response and notch signaling pathway may be the key pathway regulated by TFAP2B in EC.